An independent guide to cash-pay care. Every price is dated and sourced.

How we check

Tirzepatide in Sacramento: clinics and prices

Tirzepatide in Sacramento costs $299 to $449 a month as self-pay Zepbound from LillyDirect, checked Oct 17, 2026 [1]. Medi-Cal stopped covering GLP-1s for adult weight loss on January 1, 2026, but it can still cover them for other medically necessary uses, which matters for Mounjaro and type 2 diabetes [2].

Medical review: pending. A licensed clinician has not yet reviewed this page.

Tirzepatide is an injected GIP and GLP-1 receptor agonist taken once a week, marketed as Zepbound for weight and sleep apnea and as Mounjaro for type 2 diabetes.

Zepbound self-pay
$299 to $449 a month [1]
Medi-Cal
No adult weight loss coverage since Jan 1, 2026 [2]
Sacramento adults with diabetes
11.2% (2023) [3]
Residents 65+
14.2% [4]

Weight loss or diabetes: the label decides coverage

For Sacramento Medi-Cal members, the reason for the prescription now matters. Medi-Cal no longer pays for GLP-1s used for adult weight loss, but uses for other conditions can be covered if medically necessary [2]. Tirzepatide is sold under two labels: Mounjaro for type 2 diabetes in adults and children 10 and older [5], and Zepbound for chronic weight management and obstructive sleep apnea with obesity [6]. In Sacramento, 11.2% of adults have diagnosed diabetes [3].

Sacramento practices may buy the labeled slot above. It is an ad, and it has no say over what we write.

Cash prices a Sacramento patient sees

LillyDirect Zepbound and Mounjaro list price, Sacramento view (Oct 17, 2026)
What you buyMonthly costNotes
Zepbound 2.5 mg, first four weeks$299 [1]Pen or vial, 28-day supply
Zepbound 5 mg$399 [1]Same price either form
Zepbound 7.5 mg to 15 mg$449 [1]Holds only with a refill within 45 days
Mounjaro, diabetes brand, list$1,112.16 per 28 days [7]Four pens; insurance usually applies
Vial and KwikPen prices match. Every buying channel: tirzepatide cost.

Let that refill slip past day 45 and LillyDirect bills its regular rate: $499 for 7.5 mg, $699 for 10, 12.5 or 15 mg [1]. A calendar reminder is cheap insurance.

Medicare: the KwikPen detail

With 14.2% of Sacramento residents 65 or older [4], Medicare questions come up often. The Medicare GLP-1 Bridge covers the Zepbound KwikPen, but not Zepbound vials or single-dose pens, for eligible Part D enrollees at a $50 monthly copay through December 31, 2027 [8] [9]. Eligibility depends on BMI plus certain conditions, such as a BMI of 35 or higher, or 27 or higher with prediabetes or a prior heart attack or stroke [9]. Details: Medicare and GLP-1s.

Compounded and research-use tirzepatide

Compounded tirzepatide is not FDA-approved, and FDA does not review it for safety, effectiveness or quality [10]. Products labeled for research use only are not meant for people at all, and FDA has warned companies that sell research-use GLP-1s [10]. See compounded tirzepatide and research-use-only GLP-1s. Check California prescribers with the Medical Board of California [11].

Other West Coast pages: Los Angeles, San Diego, Las Vegas and, farther north, Seattle. Background: tirzepatide guide.

Label cautions

Before the first Sacramento dose

Anyone with MEN 2, or with medullary thyroid carcinoma in themselves or the family, should not take tirzepatide; that is the boxed warning. Pain in the belly that is severe and keeps going needs a doctor quickly. Combining it with a sulfonylurea or insulin can drop blood sugar too low: in a diabetes trial where people also took a sulfonylurea, 10.3% on tirzepatide had low blood sugar [12]. Pregnancy means stopping. A serious allergic reaction is a 911 call.

Questions people ask

What will a Sacramento cash buyer pay for Zepbound?

LillyDirect charged $299 for the 2.5 mg starter, $399 for 5 mg, and $449 for 7.5 to 15 mg with refills inside 45 days, as of Oct 17, 2026 [1].

Can a Sacramento Medi-Cal member still get Mounjaro for diabetes?

Medi-Cal dropped GLP-1 coverage for adult weight loss on January 1, 2026, yet non-weight-loss uses may be covered when medically necessary [2]. Mounjaro's label is for type 2 diabetes [5].

Which Zepbound form works with Medicare's Bridge?

Only the KwikPen. The Medicare GLP-1 Bridge leaves out Zepbound vials and single-dose pens [8].

What share of Sacramento adults have diabetes?

CDC PLACES estimates 11.2% of adults in the city of Sacramento had diagnosed diabetes in 2023 [3].

How many Sacramento residents are 65 or older?

The Census Bureau puts the share at 14.2% of city residents [4].

What did long-term tirzepatide use show in SURMOUNT-4?

Those who stayed on tirzepatide for 88 weeks averaged a 25.3% weight reduction, against 9.9% for people switched to placebo after week 36 [13].

Sources

13 cited
  1. Zepbound self-pay pricing. Eli Lilly and Company (LillyDirect), accessed 2026-10-17.
  2. California Medicaid ends coverage of GLP-1 weight loss drugs. KFF Health News, Jan 9, 2026.
  3. PLACES place data: Sacramento, CA. CDC PLACES (2025 release, BRFSS 2023), 2023 data, 2025 release.
  4. QuickFacts: Sacramento city, California. U.S. Census Bureau, QuickFacts, V2025; ACS 2020-2024.
  5. Mounjaro label. DailyMed, NLM, Aug 2026.
  6. Zepbound label. DailyMed, NLM, Aug 2026.
  7. Mounjaro FAQ: pricing. Eli Lilly and Company, accessed 2026-10-17.
  8. Medicare GLP-1 Bridge: information for pharmacies. Centers for Medicare & Medicaid Services, accessed 2026-10-17.
  9. Weight loss drugs coverage. Medicare.gov (CMS), accessed 2026-10-17.
  10. FDA's concerns with unapproved GLP-1 drugs used for weight loss. US Food and Drug Administration, Oct 1, 2026.
  11. Medical Board of California. Medical Board of California, accessed 2026-10-17.
  12. Zepbound prescribing information. US FDA (accessdata.fda.gov), Apr 2026.
  13. Continued treatment with tirzepatide for maintenance of weight reduction (SURMOUNT-4). JAMA (PubMed), Jan 1, 2024.

This page is general information, not medical advice. Talk with a licensed clinician about your own care.

See the cheapest tirzepatide options